iCAD's revenue decline in Q3

Michael Bassett | October 30, 2009 | Health Exec | Precision Medicine

iCAD reported a drop of in revenue in the third quarter of 2009, which ended Sept. 30.

The Nashua, N.H.-based company posted total revenue of 7.1 million in the third quarter, more than $4 million less than the $11.2 million reported in the same quarter a year ago. Net income for the quarter was $113,000, compared to the $2.1 million posted in the third quarter of 2008.

iCAD, a provider of image analysis and workflow solutions, reported $4.8 million in digital computer-aided detection (CAD) and MRI revenue in the third quarter, down from the $8.2 million posted in the year-ago quarter. Film-based revenue declined to $1.3 million from $2.2 million a year ago.

Michael Bassett,

Contributor

Around the web

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

AI in Healthcare

4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

iCAD's revenue decline in Q3

Related Content

Around the web